| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
1 company
Koski Family LP last filed a Form 4 in September 2018, as 10% Owner at OGEN.
At the last filing, the largest reported position was 277,839 shares of OGEN. Net of sales, the OGEN filings show accumulation of 5,984,130 shares.
Koski Family LP has 10 Form 4 filings on record from March 2015 to September 2018, all as 10% Owner at Oragenics (OGEN), 2015–2018.
The 23 reported transactions were 7 option or other derivative awards, 7 open-market purchases, 6 stock awards and 2 other transactions, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $3.1M and no sales.
The largest open-market purchase was 5,815,080 shares of OGEN at an average $0.52 on June 30, 2016, about $3.0M.
Shares as reported in the last Form 4 for each company; the most recent is from September 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.